Stent with optimal strength and radiopacity characteristics

Details Stent with optimal strength and radiopacity characteristics Stent with optimal strength and radiopacity characteristics

2008-03-04

2008-03-04

McDermott, Corrine (Department: 3738)

Prosthesis (i.e., artificial body members), parts thereof, or ai

Arterial prosthesis

Stent structure

Reexamination Certificate

active

10717470

ABSTRACT:
A stent in the form of a thin-walled, multi-cellular tubular structure is provided. The tubular structure has a longitudinal axis and the stent includes a plurality of circumferential sets of strut members. Each set of the strut members is longitudinally displaced from each other and connected to each other by longitudinally extending links. Each set of the strut members forms a closed and cylindrical portion of the stent. Further, each set of the strut members includes a plurality of connected curve sections and diagonal sections. The sets of the strut members further include end sets of strut members located at each end of the stent and central sets of strut members located between the end sets of the strut members.

REFERENCES:
patent: 3657744 (1972-04-01), Ersek
patent: 4441216 (1984-04-01), Ionescu et al.
patent: 4503569 (1985-03-01), Dotter
patent: 4553545 (1985-11-01), Maass et al.
patent: 4580568 (1986-04-01), Gianturco
patent: 4733665 (1988-03-01), Palmaz
patent: 4776337 (1988-10-01), Palmaz
patent: 4800882 (1989-01-01), Gianturco
patent: 4856516 (1989-08-01), Hillstead
patent: 4886062 (1989-12-01), Wiktor
patent: 4907336 (1990-03-01), Gianturco
patent: 4969458 (1990-11-01), Wiktor
patent: 4990131 (1991-02-01), Dardik et al.
patent: 4990155 (1991-02-01), Wilkoff
patent: 4994071 (1991-02-01), MacGregor
patent: 5015253 (1991-05-01), MacGregor
patent: 5035706 (1991-07-01), Gianturco et al.
patent: 5041126 (1991-08-01), Gianturco
patent: 5064435 (1991-11-01), Porter
patent: 5102417 (1992-04-01), Palmaz
patent: 5104404 (1992-04-01), Wolff
patent: 5116365 (1992-05-01), Hillstead
patent: 5122154 (1992-06-01), Rhodes
patent: 5131908 (1992-07-01), Dardik et al.
patent: 5133732 (1992-07-01), Wiktor
patent: 5135536 (1992-08-01), Hillstead
patent: 5163958 (1992-11-01), Pinchuk
patent: 5171262 (1992-12-01), MacGregor
patent: 5176660 (1993-01-01), Truckai
patent: 5178618 (1993-01-01), Kandarpa
patent: 5192307 (1993-03-01), Wall
patent: 5195984 (1993-03-01), Schatz
patent: 5217483 (1993-06-01), Tower
patent: 5222971 (1993-06-01), Willard et al.
patent: 5246445 (1993-09-01), Yachia et al.
patent: 5258021 (1993-11-01), Duran
patent: 5266073 (1993-11-01), Wall
patent: 5275622 (1994-01-01), Lazarus et al.
patent: 5282823 (1994-02-01), Schwartz et al.
patent: 5282824 (1994-02-01), Gianturco
patent: 5290305 (1994-03-01), Inoue
patent: 5292331 (1994-03-01), Boneau
patent: 5304200 (1994-04-01), Spaulding
patent: 5313444 (1994-05-01), Gianturco
patent: 5314472 (1994-05-01), Fontaine
patent: 5334301 (1994-08-01), Heinke et al.
patent: 5342348 (1994-08-01), Kaplan
patent: 5342387 (1994-08-01), Summers
patent: 5354257 (1994-10-01), Roubin et al.
patent: 5354308 (1994-10-01), Simon et al.
patent: 5366504 (1994-11-01), Andersen et al.
patent: 5370683 (1994-12-01), Fontaine
patent: 5370691 (1994-12-01), Samson
patent: 5375612 (1994-12-01), Cottenceau et al.
patent: 5376112 (1994-12-01), Duran
patent: 5382261 (1995-01-01), Palmaz
patent: 5387235 (1995-02-01), Chuter
patent: 5389106 (1995-02-01), Tower
patent: 5395390 (1995-03-01), Simon et al.
patent: 5397355 (1995-03-01), Marin et al.
patent: 5403341 (1995-04-01), Solar
patent: 5405377 (1995-04-01), Cragg
patent: 5411549 (1995-05-01), Peters
patent: D359802 (1995-06-01), Fontaine
patent: 5421955 (1995-06-01), Lau et al.
patent: 5423885 (1995-06-01), Williams
patent: 5441515 (1995-08-01), Khosravi et al.
patent: 5441516 (1995-08-01), Wang et al.
patent: 5443477 (1995-08-01), Marin et al.
patent: 5443496 (1995-08-01), Schwartz et al.
patent: 5443498 (1995-08-01), Fontaine
patent: 5443500 (1995-08-01), Sigwart
patent: 5449372 (1995-09-01), Schmaltz et al.
patent: 5449373 (1995-09-01), Pinchasik et al.
patent: 5449382 (1995-09-01), Dayton
patent: 5496365 (1996-03-01), Sgro
patent: 5527354 (1996-06-01), Fontaine et al.
patent: 5569295 (1996-10-01), Lam
patent: 5591197 (1997-01-01), Orth et al.
patent: 5609629 (1997-03-01), Fearnot et al.
patent: 5632763 (1997-05-01), Glastra
patent: 5643312 (1997-07-01), Fischell et al.
patent: 5649952 (1997-07-01), Lam
patent: 5653747 (1997-08-01), Dereume
patent: 5669924 (1997-09-01), Shaknovich
patent: 5697971 (1997-12-01), Fischell et al.
patent: 5725572 (1998-03-01), Lam et al.
patent: 5755734 (1998-05-01), Richter et al.
patent: 5800508 (1998-09-01), Goicoechea et al.
patent: 5824049 (1998-10-01), Ragheb et al.
patent: 5827321 (1998-10-01), Roubin et al.
patent: 5861027 (1999-01-01), Trapp
patent: 5876449 (1999-03-01), Starck et al.
patent: 5911754 (1999-06-01), Kanesaka et al.
patent: 5913895 (1999-06-01), Burpee et al.
patent: 5935162 (1999-08-01), Dang
patent: 6190403 (2001-02-01), Fischell et al.
patent: 6231598 (2001-05-01), Berry et al.
patent: 32 05 942 (1983-09-01), None
patent: 0 540 290 (1993-05-01), None
patent: 0 540 290 (1993-05-01), None
patent: 0 800 801 (1997-10-01), None
patent: 0 824 900 (1998-02-01), None
patent: 0 830 853 (1998-03-01), None
patent: 0 734 698 (1998-08-01), None
patent: 0 916 317 (1999-05-01), None
patent: 566 807 (1924-02-01), None
patent: 0 662 307 (1951-05-01), None
patent: 1 205 743 / A5 (1970-09-01), None
patent: WO 96/26689 (1996-09-01), None
patent: WO 96/34580 (1996-11-01), None
patent: WO 97/25000 (1997-07-01), None
patent: WO 98/19628 (1998-05-01), None
patent: WO0053122 (2000-09-01), None
patent: WO 01/00112 (2001-01-01), None

Affiliated with

Also associated with

Rating

Stent with optimal strength and radiopacity characteristics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stent with optimal strength and radiopacity characteristics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent with optimal strength and radiopacity characteristics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3927474